Oncotarget Is Changing The Way Knowledge Spreads

We all understand how technology is changing day to day life. Most of us are active on social media. But few people in the general public know how the internet is impacting medical research. While the scientific method remains the same, the ability of scientists to share knowledge has evolved rapidly over the years. Oncotarget’s new publishing model has shaken up the world of biomedical research.

Oncotarget is fast becoming one of the most important biomedical journals in the world. Traditionally, this journal has followed a standard publication schedule and focused on oncology. But recently, it has started publishing twice per week. This is a significant shift from the traditional formats most journals follow. With more issues, more people have the opportunity to publish. And more information in total is being communicated. Learn more about Oncotarget at researchgate.net

Oncotarget has also broadened its scope. It’s begun to feature cutting-edge studies across a number of fields. The link is that all articles are biomedical in nature. Whether it’s mutations in the fruit fly (Drosophila), DNA markers found in spit, or the effects of Vitamin E on cancers, Oncotarget reports on it all. By providing this peer-reviewed material as quickly as possible, the publication helps scientific knowledge spread quickly and efficiently. Check Oncotarget journal at scimagojr.com

Oncotarget is now publishing online through an open-access model. They they providing the material to PubMed after two or three days. This model has radically changed the way students, researchers and practicing doctors access new information. The feedback loop has become smaller. There’s less of a lag between discovery and implementation.

Visit: https://www.facebook.com/Oncotarget/

Dr. David Samadi: Dedicated To Health Awareness

Dr. David Samadi, Fox News contributor, will be hosting live broadcasts called “Sunday Housecall with Dr. David Samadi”. Dr. David Samadi will discuss relevant medical stories and health issues, while providing healthy tips and information for its viewers. Broadcasts are scheduled to start in September.

The show ” Sunday House call with Dr. David Samadi” will air live on Sundays at 12:30 pm ET. The show will air live on Twitter, Facebook, YouTube, and on DrSamadiTV.com. On the show, viewers can also expect guest appearances by medical and health and wellness specialists, to discuss topics of interest with Dr. Samadhi. The main goal of the broadcast is to provide answers to its viewers on health questions and provide healthy advice as well.

Some of the topics Dr. Samadi will discuss are diet and exercise, women and men’s health, prostate health, diseases that are common for everyone, trending health topics, and healthy sex.

During the live broadcast, viewers will be able to ask any health questions they may have via phone or email. Every question will be answered on e show or after the show by Dr. Samadi or by another specialist that is able to answer that question.

Any specialists are invited to collaborate as a guest with Dr. Samadi during his live broadcasts. Specialists who have developed extensive knowledge on health topics, authored books on health topics, and developed peer reviewed health or medical products are encouraged to contact Dr. Samadi at phone number, 212-365-5000.

Some Information About Dr. Samadi

Dr. David Samadi serves as Chairman of Urology at Lenox Hill Hospital. He is also Chief of Robotic Surgery there. Dr. Samadi is board certified in urologic oncology and has an expertise in robotic prostate surgery. He has dedicated his medical career to provide early detection and treatment of prostate cancer. He dedicates time to spread the message of how important early detection is for prostate cancer worldwide. Prostate cancer is the second highest cause for death in men. Through his live broadcast on these platforms, it will help increase this awareness to a much larger audience.

Amicus Therapeutics Works to Bring Hope To Patients and Families Dealing With Genetic Disorders

In the forefront of advanced therapy, Amicus Therapeutics Inc is leading the way as a biotechnology company. They help to treat a range of rare and orphaned diseases which people are forced to deal with yearly due to genetic diseases.


Currently their number one candidate is Migalastat, the late stage development medicine that is being used in individuals who have Fabry disease. SD-101 is a product that is a candidate with late stage development that is hoped to be the first in class to market therapy in the rare connective tissue disorder that is passed down genetically from one person to another (https://www.crunchbase.com/organization/amicus-therapeutics).


Amicus Therapeutics will work with to ensure that individual patients and their caregivers are doing and receiving everything they can in order to support individuals who have rare diseases. They will work to ensure that families, patients, caregivers and others have the access they need in order to have support and services across all experiences with their disease. It is the goal of Amicus Therapeutics to deliver healing even further than the disease.


Amicus Therapeutics is also looking for the better and new therapies that are out there for patients suffering from genetic disorders and diseases. They will incorporate the input from their patients during clinical trials of therapies which offer research advances in the drug developments processes. They will also provide any useful information as well as resources to help to manage what each patient is met with daily when it comes to living with genetic diseases year after year.


Amicus Therapeutics has a number of tactics that they use to deliver the benefits that their patients and their families gets from them (YahooFinance). There are several treatment options being developed at one time to help ensure that rare diseases are being addressed each year. Amicus also searches for ways that they can be active within the community by participating in events which educate and support patients who might not know that they are out there. They push to advocate for patients and their families as they start to navigate within the rare disease community. If you are faced with or know someone with a rare genetic disorder, Amicus Therapeutics could be what you need.

Startups prosper with Marc Sparks’ valuable guidance

Marc Sparks, the venture capitalist and serial entrepreneur based out of Dallas, Texas, has put together an extremely impressive portfolio in the business world, all acquired through hard work, confidence, and perseverance.Learn more : http://www.prnewswire.com/news-releases/entrepreneur-marc-sparks-transforms-office-to-optimize-innovative-collaboration-300024747.html


Mr. Sparks, who has had experience in venture investing, real estate, auto insurance, and business solutions, to name but a few of his past accomplishments, has turned his diverse experience in the business world into an invaluable asset that has aided many others in the business community in realizing their own success and prosperity.


With a rather pedestrian C+ grade point average in high school, and no formal college education, Mr. Sparks has used his unique business sense and talent to help startup business owners realize the success they so dearly need to help them grow and develop. As an expert in business planning and strategy, he has helped guide to success more than 60 startup companies to date.


Mr. Sparks, who loves to create “magical and wonderful businesses from scratch”, elected to put his experience and passion for helping business owners into a much more recognized and open medium. Authoring the book ‘They Can’t Eat You‘, he hopes to inspire others with his own story, highlighting his personal life. In the text, he goes on to trace a path to success that he hopes others will follow. Perhaps the bottom line of the text is that, through confidence, anyone can become a success in business.


In addition to his significant business accomplishments, Mr. Sparks has proven to be a terrific philanthropist in the Dallas area. Since the late 1980s, he has been involved with the Samaratin Inn, a “zero tolerance” homeless shelter greatly assisting many in the Dallas area. His contributions, significant financially as they are, are most certainly not limited to giving dollars and cents. He has helped build homes for Habitats for Humanity, and is a passionate supporter of American Can! Academy, a high school magnet program in Dallas.


The founder, owner, and CEO of Timber Creek Capital, Mr. Sparks has created an immensely successful website and blog. In his blog, he writes about such important topics as inspiring experiences in entrepreneurship; business successes and failures; and other diverse areas which include faith and tenacity, food, health/exercise, and world travel.